Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
06:45am, Tuesday, 23'rd Jul 2024
Second quarter revenues of $2.40 billion, up 2.5% from 2023 Second quarter reported diluted earnings per share ("EPS") of $2.03, down 1.0% from 2023; and adjusted diluted EPS of $2.35, up 2.2% from 20
BALTIMORE, Md. and BASKING RIDGE, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, and Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pha
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
10:51am, Wednesday, 17'th Jul 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?
10:15am, Tuesday, 16'th Jul 2024
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Quest Diagnostics (DGX) Set to Acquire OhioHealth's Lab Services
09:36am, Monday, 15'th Jul 2024
Quest Diagnostics' (DGX) new agreement is likely to help expand access to cost-effective and advanced laboratory services in Ohio.
What Awaits Quest Diagnostics (DGX) in Q2 Earnings Release?
10:41am, Friday, 12'th Jul 2024
Quest Diagnostics (DGX) is likely to have maintained its robust base business performance in the second quarter of 2024. However, nosediving COVID-19 testing revenues may limit growth.
Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth
08:58am, Wednesday, 10'th Jul 2024
Goal to broaden access to cost-effective and innovative laboratory services in Ohio SECAUCUS, N.J. and COLUMBUS, Ohio , July 10, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider
Quest Diagnostics (DGX) to Expand in Canada With LifeLabs Buyout
12:15pm, Thursday, 04'th Jul 2024
By integrating LifeLabs into its operations, Quest Diagnostics (DGX) aims to enhance the accessibility and quality of diagnostic services for Canadians.
Quest Diagnostics to acquire LifeLabs for $985 million
09:01am, Wednesday, 03'rd Jul 2024
Quest Diagnostics said on Wednesday it would acquire LifeLabs, a provider of community laboratory tests, from OMERS for about C$1.35 billion, or about $985 million.
Quest Diagnostics to acquire Canada's LifeLabs for about $985 million including debt
08:56am, Wednesday, 03'rd Jul 2024
Quest Diagnostics Inc. DGX, -0.33% said Wednesday it has entered a definitive agreement with pension fund OMERS to acquire LifeLabs, a Canadian provider of community laboratory services, for about C$1
Quest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians
08:45am, Wednesday, 03'rd Jul 2024
SECAUCUS, N.J. and TORONTO , July 3, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a definitive agreement with OMERS to ac
Quest Diagnostics (DGX) Inks Deal to Acquire Allina Health
10:45am, Thursday, 27'th Jun 2024
Quest Diagnostics (DGX) signs an agreement to acquire Allina Health's select laboratory assets. The deal is aimed at expanding Quest Diagnostics' laboratory services across Minnesota and western Wisco
Quest Diagnostics Releases 2023 Corporate Responsibility Report
06:45am, Thursday, 27'th Jun 2024
SECAUCUS, N.J. , June 27, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today released its 2023 Corporate Responsibility Report.
Quest Diagnostics to Acquire Select Lab Assets from Allina Health
04:03pm, Wednesday, 26'th Jun 2024
Transaction to broaden access to Quest's innovative and cost-effective services for providers and patients in Minnesota and western Wisconsin SECAUCUS, N.J. and MINNEAPOLIS , June 26, 2024 /PRNewsw
Is It Apt to Hold Quest Diagnostics (DGX) Stock for Now?
09:35am, Wednesday, 26'th Jun 2024
Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues pose concerns.
